STRATEC Biomedical AG announced that Bernd M. Steidle, (Member, Board of Management, Marketing and Sales) has left the Board of Management as of March 19, 2014 and will have no further involvement in the company's operations. The company structures in the fields of marketing and sales will now be realigned under the management of company CEO Marcus Wolfinger.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.4 EUR | -0.24% | -4.16% | -8.89% |
Apr. 29 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
Apr. 26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.89% | 542M | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.10% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- SBS Stock
- News Stratec SE
- Bernd M. Steidle Will Leave STRATEC Biomedical AG as Member, Board of Management, Marketing and Sales